-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Atrial natriuretic factor (ANF) is a hormone that is synthesized and released by the heart in response to increased blood pressure.
It plays a crucial role in the regulation of blood pressure and the maintenance of fluid balance in the body.
ANF has been found to have a wide range of therapeutic applications, including the treatment of hypertension, heart failure, and renal disease.
In the chemical industry, the synthetic routes of ANF have been a topic of great interest due to its potential use as a therapeutic agent.
This article will explore the various synthetic routes that have been developed to synthesize ANF (1-28) (human) acetate salt.
One of the most commonly used synthetic routes for ANF (1-28) (human) acetate salt is the solid-phase peptide synthesis (SPPS) method.
This method involves the sequential coupling of peptide building blocks on a solid support, such as a resin or a bead.
The SPPS method offers several advantages, including the ability to produce large quantities of ANF with high purity and the ability to easily modify the peptide chain.
One disadvantage of the SPPS method is that it can be time-consuming and costly, as a large number of steps are required to synthesize the full peptide.
Another synthetic route for ANF (1-28) (human) acetate salt is the liquid-phase peptide synthesis (LPPS) method.
This method involves the synthesis of the peptide chain in solution, using a variety of protecting groups and deprotecting reagents to keep the peptide chain stable.
The LPPS method offers several advantages, including the ability to synthesize the full peptide in a single step and the ability to easily modify the peptide chain.
One disadvantage of the LPPS method is that it can be difficult to purify the final product, as the peptide chain is not attached to a solid support.
A third synthetic route for ANF (1-28) (human) acetate salt is the automated peptide synthesizer.
This method involves the use of an automated peptide synthesizer that performs all the steps of the synthesis in a fully automated manner.
The automated peptide synthesizer offers several advantages, including the ability to produce large quantities of ANF with high purity in a short period of time.
One disadvantage of the automated peptide synthesizer is that it can be expensive to purchase and maintain.
In conclusion, the synthetic routes of ANF (1-28) (human) acetate salt have been the subject of much research in the chemical industry.
The SPPS, LPPS, and automated peptide synthesizer methods are three commonly used methods for synthesizing ANF.
Each method offers its own advantages and disadvantages, and the choice of method will depend on the specific applications and goals of the researcher.
It is likely that further research will continue to develop new and more efficient methods for synthesizing ANF, leading to new and improved therapeutic applications.